Ichiro Kinoshita

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 103 publications

Factors Associated With Rash in Elderly Patients Receiving Carboplatin Plus Pemetrexed With Dexamethasone Prophylaxis.

Factors Associated With Rash in Elderly Patients Receiving Carboplatin Plus Pemetrexed With Dexamethasone Prophylaxis.

Journal: Anticancer research

Published: June 08, 2026

Identification of Factors Associated With Clinically Problematic Hiccups in Male Patients Receiving Cisplatin-based Treatment With Dexamethasone and Aprepitant: A Subgroup Analysis.

Identification of Factors Associated With Clinically Problematic Hiccups in Male Patients Receiving Cisplatin-based Treatment With Dexamethasone and Aprepitant: A Subgroup Analysis.

Journal: In vivo (Athens, Greece)

Published: May 12, 2026

Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

Journal: Cancer science

Published: April 07, 2026

Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study.

Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study.

Journal: Japanese journal of clinical oncology

Published: February 16, 2026

Real-world characterization of patients with advanced or metastatic liposarcoma, including dedifferentiated liposarcoma, in Japan in the MASTER KEY project.

Real-world characterization of patients with advanced or metastatic liposarcoma, including dedifferentiated liposarcoma, in Japan in the MASTER KEY project.

Journal: Japanese journal of clinical oncology

Published: September 04, 2025

Impact of baseline regular magnesium oxide administration on chemotherapy-induced constipation during cisplatin-containing treatment.

Impact of baseline regular magnesium oxide administration on chemotherapy-induced constipation during cisplatin-containing treatment.

Journal: International journal of clinical oncology

Published: August 13, 2025

Author's reply to "Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer".

Author's reply to "Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer".

Journal: Japanese journal of clinical oncology

Published: August 07, 2025

Evaluation of factors associated with clinically problematic hiccups in cisplatin-containing treatment with dexamethasone and neurokinin 1 receptor antagonists.

Evaluation of factors associated with clinically problematic hiccups in cisplatin-containing treatment with dexamethasone and neurokinin 1 receptor antagonists.

Journal: International journal of clinical oncology

Published: July 24, 2025

Characterization of the mutational landscapes in Japanese patients with early-onset colorectal cancer from comprehensive genomic profiling data.

Characterization of the mutational landscapes in Japanese patients with early-onset colorectal cancer from comprehensive genomic profiling data.

Journal: International journal of clinical oncology

Published: July 17, 2025

Clinical utility of comprehensive genomic profiling test for colorectal cancer: a single institution prospective observational study.

Clinical utility of comprehensive genomic profiling test for colorectal cancer: a single institution prospective observational study.

Journal: Journal of cancer research and clinical oncology

Published: July 13, 2025

Earlier Comprehensive Cancer Genomic Profiling in Gynecologic Cancers May Facilitate Genotype-Matched Therapy: A Prospective Single-Institution Study.

Earlier Comprehensive Cancer Genomic Profiling in Gynecologic Cancers May Facilitate Genotype-Matched Therapy: A Prospective Single-Institution Study.

Journal: Obstetrics and gynecology international

Published: June 18, 2025

Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer.

Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer.

Journal: Japanese journal of clinical oncology

Published: April 27, 2025

Showing 1-12 of 103

Last Updated: 09/26/2026